S Fanti

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi request reprint Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT
    Claudia Testa
    Department of Clinical Medicine and Applied Biotechnology D Campanacci, Diagnostic Imaging Section V Bollini, Pathologic Anatomy Unit, Institute of Oncology F Addarii, P E T Center, Policlinico S Orsola Malpighi, University of Bologna, Italy
    Radiology 244:797-806. 2007
  2. ncbi request reprint PET/CT and radiotherapy in gynecological cancer
    P Caroli
    Department of Nuclear Medicine, Policlinico Sant Orsola Malpighi, Bologna University, Bologna, Italy
    Q J Nucl Med Mol Imaging 54:533-42. 2010
  3. doi request reprint Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET
    Stefano Fanti
    Unità Operativa di Medicina Nucleare, Padiglione 30, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    Ann Nucl Med 22:429-32. 2008
  4. doi request reprint PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
    Stefano Fanti
    Department of Nuclear Medicine, S Orsola Malpighi University Hospital, PAD 30, Via Massarenti 9, 40138, Bologna, Italy
    Eur J Nucl Med Mol Imaging 43:55-69. 2016
  5. pmc Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series
    Michele Bartoletti
    Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico S, Orsola Malpighi, Alma Mater Studiorum Universita di Bologna, Bologna, Italy
    BMC Res Notes 7:32. 2014
  6. pmc Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET
    Maria Abbondanza Pantaleo
    Department of Hematology and Oncology Sciences L A Seragnoli, Sant Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    J Exp Clin Cancer Res 29:173. 2010
  7. doi request reprint Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view
    R Schiavina
    Department of Urology, University of Bologna, Bologna, S Orsola Malpighi Hospital, Italy
    Rev Esp Med Nucl Imagen Mol 32:310-3. 2013
  8. doi request reprint Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer
    M A Pantaleo
    Institute of Hematology and Medical Oncology L A Seragnoli, Sant Orsola Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy
    Ann Oncol 20:213-26. 2009
  9. ncbi request reprint Positron-emission tomography in imaging and staging prostate cancer
    M Farsad
    Nuclear Medicine PET Center, S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    Cancer Biomark 4:277-84. 2008
  10. ncbi request reprint 18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours
    C Nanni
    Nuclear Medicine Department, PET CT Unit, Policlinico S Orsola Malpighi, Bologna, Italy
    Biomed Pharmacother 60:593-606. 2006

Detail Information

Publications118 found, 100 shown here

  1. ncbi request reprint Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT
    Claudia Testa
    Department of Clinical Medicine and Applied Biotechnology D Campanacci, Diagnostic Imaging Section V Bollini, Pathologic Anatomy Unit, Institute of Oncology F Addarii, P E T Center, Policlinico S Orsola Malpighi, University of Bologna, Italy
    Radiology 244:797-806. 2007
    ....
  2. ncbi request reprint PET/CT and radiotherapy in gynecological cancer
    P Caroli
    Department of Nuclear Medicine, Policlinico Sant Orsola Malpighi, Bologna University, Bologna, Italy
    Q J Nucl Med Mol Imaging 54:533-42. 2010
    ....
  3. doi request reprint Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET
    Stefano Fanti
    Unità Operativa di Medicina Nucleare, Padiglione 30, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    Ann Nucl Med 22:429-32. 2008
    ..This case testifies the possibility of early relapse of lymphoma even in the case of negative interim PET; it also supports the usefulness of end-treatment PET scan in lymphoma patients...
  4. doi request reprint PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
    Stefano Fanti
    Department of Nuclear Medicine, S Orsola Malpighi University Hospital, PAD 30, Via Massarenti 9, 40138, Bologna, Italy
    Eur J Nucl Med Mol Imaging 43:55-69. 2016
    ....
  5. pmc Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series
    Michele Bartoletti
    Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico S, Orsola Malpighi, Alma Mater Studiorum Universita di Bologna, Bologna, Italy
    BMC Res Notes 7:32. 2014
    ....
  6. pmc Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET
    Maria Abbondanza Pantaleo
    Department of Hematology and Oncology Sciences L A Seragnoli, Sant Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    J Exp Clin Cancer Res 29:173. 2010
    ..We report a preclinical study on drug combinations in a xenograft model of GIST in which effects on tumor dimensions and metabolic activity were assessed by small animal PET imaging...
  7. doi request reprint Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view
    R Schiavina
    Department of Urology, University of Bologna, Bologna, S Orsola Malpighi Hospital, Italy
    Rev Esp Med Nucl Imagen Mol 32:310-3. 2013
    ..Low sensitivity, costs, availability of technologies and confirmation of the results remain the major limitations in most cases...
  8. doi request reprint Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer
    M A Pantaleo
    Institute of Hematology and Medical Oncology L A Seragnoli, Sant Orsola Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy
    Ann Oncol 20:213-26. 2009
    ..As a consequence, various critical questions are still open, and the implications of a translation in the clinical setting for EGFr imaging in cancer patients is discussed...
  9. ncbi request reprint Positron-emission tomography in imaging and staging prostate cancer
    M Farsad
    Nuclear Medicine PET Center, S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    Cancer Biomark 4:277-84. 2008
    ..At present, the only clinical indication for imaging PCa with 11C-choline-PET is evaluation of suspected recurrence after treatment...
  10. ncbi request reprint 18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours
    C Nanni
    Nuclear Medicine Department, PET CT Unit, Policlinico S Orsola Malpighi, Bologna, Italy
    Biomed Pharmacother 60:593-606. 2006
    ..It will also discuss the physiologic biodistribution of 18F-FDG, outlining the normal variants in the paediatric patients that may lead to misinterpretation...
  11. ncbi request reprint 18F-FDG small animal PET for early detection of human anaplastic large cells lymphoma xenograft in immunocompromised mice
    V Ambrosini
    Unità operative di Medicina Nucleare, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Italy
    Anticancer Res 28:981-7. 2008
    ..PET was positive in 6/8 (75%) animals, detecting the presence of viable tumour cells earlier than macroscopic evaluation, thus may be used for the early identification of tumour bearing animals...
  12. doi request reprint MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
    E Derenzini
    Department of Haematology and Medical Oncology, University of Bologna, Bologna, Italy
    Ann Oncol 21:1173-8. 2010
    ..Adult Langerhans cell histiocytosis (LCH) is a rare disease. The combination of vinblastine and prednisone, given in a 6-month course, is the standard of care but prospective randomized trials are lacking...
  13. ncbi request reprint The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?
    R Schiavina
    Department of Urology, University of Bologna, Bologna, S Orsola Malpighi Hospital, Italy
    Curr Radiopharm 6:92-5. 2013
    ..The aim of the present paper is to evaluate the management of patients with BCR after radical treatment of PCa from the urologist point of view. ..
  14. ncbi request reprint 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin
    V Ambrosini
    Unità Operativa di Medicina Nucleare, Padiglione 30, Policlinico S Orsola Malpighi, Via Massarenti 9, I 40138, Bologna, Italy
    Radiol Med 111:1146-55. 2006
    ..The aim of this study was to assess the role of 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) in the identification of occult primary cancers...
  15. doi request reprint FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study
    E Lopci
    Nuclear Medicine Department, University Hospital S Orsola Malpighi, Bologna, Italy
    Ann Oncol 21:1877-83. 2010
    ....
  16. pmc Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding
    S Fanti
    Nuclear Medicine Service PET Unit, S Orsola Malighi Hospital, University of Bologna, Bologna, Italy
    Cancer Imaging 6:20-3. 2006
    ....
  17. ncbi request reprint [18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy
    A A Martoni
    Unit of Medical Oncology, S Orsola Malpighi University Hospital, Bologna, Italy
    Q J Nucl Med Mol Imaging 55:81-90. 2011
    ..However a percentage of patients could benefit from additional courses. [(18)F]FDG-PET/CT monitoring during na-CHT could predict early pathological response and allow the delivery of an optimal na-CHT duration...
  18. ncbi request reprint Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses
    D Rubello
    Department of Nuclear Medicine, S Maria della Misericordia Hospital, Rovigo, Italy
    Panminerva Med 47:187-9. 2005
    ..The aim of the present study was to assess the accuracy of an hybrid PET/CT scanner in the evaluation of newly diagnosed parotid masses, comparing the results with those reported in the literature with using PET scanners only...
  19. doi request reprint A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
    P L Zinzani
    Institute of Hematology and Medical Oncology L e A Seràgnoli, Policlinico Sant Orsola Malpighi, University of Bologna, Bologna, Italy
    Ann Oncol 23:415-20. 2012
    ....
  20. doi request reprint Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging
    M C Marzola
    Department of Nuclear Medicine, Medical Physics, Radiology, Santa Maria della Misericordia Hospital, Viale Tre Martiri 140, 45100, Rovigo, Italy
    Eur J Surg Oncol 36:414-21. 2010
    ..To evaluate the role of a multi-imaging PET with (18)F-DOPA and (18)F-FDG in comparison with conventional imaging (CI) in recurrent medullary thyroid carcinoma (MTC)...
  21. doi request reprint Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients
    G Brandi
    Institute of Hematology and Medical Oncology L and A Seragnoli, University of Bologna, Bologna, Italy
    Chemotherapy 54:421-4. 2008
    ..Molecular imaging techniques seem to be mandatory in the era of tailored therapy since it is useful to have an in vivo 'biological picture' of the neoplastic disease...
  22. ncbi request reprint FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma
    E Lopci
    S Orsola Malpighi Policlinic, Bologna, Italy
    Q J Nucl Med Mol Imaging 54:436-41. 2010
    ..In this paper we investigate its value in patients affected by follicular lymphoma (FL) before and after treatment with [90Y]Ibritumomab Tiuxetan (Zevalin(R))...
  23. ncbi request reprint Early predictive value of 18F-FDG-PET assessment in advanced esophagogastric junction and gastric cancer patients treated with cetuximab-containing therapy
    F Di Fabio
    Medical Oncology Unit, S Orsola Malpighi Hospital, Bologna, Italy Nuclear Medicine Unit, S Orsola Malpighi Hospital, Bologna, Italy Medical Physics Unit, S Orsola Malpighi Hospital, Bologna, Italy
    J Clin Oncol 27:e15601. 2009
    ..The aim of this study is to evaluate the usefulness of an early change in PET at several time-points in predicting response to cetuximab-containing therapy in pts with advanced GEJ or G cancer...
  24. doi request reprint Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease
    P Spinnato
    Imaging Division, Clinical Department of Radiological and Histocytopathological Sciences, University of Bologna, Sant Orsola Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy
    Eur J Radiol 81:4013-8. 2012
    ..The aim of our study was to compare the accuracy of contrast enhanced MRI and FDG PET-CT in the staging, treatment evaluation and follow-up of multiple myeloma...
  25. pmc Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model
    M A Pantaleo
    Department of Hematology and Oncology Sciences L A Seragnoli, Sant Orsola Malpighi Hospital, University of Bologna, 40138, Bologna, Italy
    Clin Exp Med 9:199-205. 2009
    ..This approach of cancer research on GISTs is crucial and essential for innovative perspectives that could cross over to other types of cancer...
  26. ncbi request reprint PET in genitourinary tract cancers
    S Fanti
    Unit of Nuclear Medicine, S Orsola Malpighi Polyclinic, Bologna, Italy
    Q J Nucl Med Mol Imaging 51:260-71. 2007
    ..In this paper, we review the current literature and our experience in role of PET in imaging cancers of the GU tract...
  27. doi request reprint Non FDG PET
    C Nanni
    Nuclear Medicine Unit, Policlinico S Orsola, University of Bologna, Bologna, Italy
    Clin Radiol 65:536-48. 2010
    ..This is especially important in the field of response assessment, where there are new agents that are targeted more specifically at angiogenesis, hypoxia, apoptosis and other processes...
  28. ncbi request reprint 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy
    Chiara Funaioli
    Medical Oncology Unit, S Orsola Malpighi Hospital, Bologna, Italy
    Tumori 93:611-5. 2007
    ..New specific studies are required to evaluate the imaging response in metastatic colorectal cancer patients especially after treatment with new, targeted agents...
  29. doi request reprint (68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours
    Valentina Ambrosini
    Department of Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Eur J Nucl Med Mol Imaging 37:722-7. 2010
    ..To retrospectively evaluate the sensitivity, specificity and accuracy of (68)Ga-DOTA-NOC PET/CT and CT alone for the evaluation of bone metastasis in patients with neuroendocrine tumour (NET)...
  30. ncbi request reprint Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I
    C Pettinato
    Medical Physics Unit, Orsola Malpighi University Hospital, Bologna, Italy
    Q J Nucl Med Mol Imaging 56:509-14. 2012
    ..The aim of this work was the evaluation of the usefulness of 124I PET/CT sequential scans to predict absorbed doses to metastatic thyroid cancer in patients undergoing 131I therapy...
  31. ncbi request reprint Clinical applications of 68Ga-DOTANOC in neuroendocrine tumours
    E Lopci
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Bologna, Italy
    Minerva Endocrinol 33:277-81. 2008
    ....
  32. ncbi request reprint Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy
    M A Pantaleo
    Institute of Hematology and Medical Oncology L and A Seragnoli, Sant Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    Cancer Treat Rev 34:103-21. 2008
    ..The aim of this review is to analyze the current role of conventional and innovative positron emission tomography (PET) radiotracers in clinical practice and to explore the promising perspectives of molecular imaging in cancer research...
  33. pmc 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma
    Cristina Nanni
    Nuclear Medicine, PET Unit, Policlinico S Orsola Malpighi, Bologna University, Italy
    World J Surg Oncol 5:68. 2007
    ..Whole body skeletal survey (WBSS), Magnetic resonance (MR) and 18F-FDG PET/CT are imaging techniques routinely used for the evaluation of bone involvement in MM patients...
  34. ncbi request reprint Imaging of NETs with PET radiopharmaceuticals
    V Ambrosini
    Department of Nuclear Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Q J Nucl Med Mol Imaging 54:16-23. 2010
    ..On-going studies are investigating the potential role of new imaging agents (bombesin, GLP-1, CCK) that specifically bind to receptors expressed on NET cells...
  35. doi request reprint Non-FDG PET in the practice of oncology
    P Caroli
    Nuclear Medicine, University of Bologna, Bologna, Italy
    Indian J Cancer 47:120-5. 2010
    ..Other tracers are used in PET utilized as markers of hypoxia inside big neoplastic masses include 18F-MISO, 64Cu-ATSM, 18F-EF5, which highlight the presence of hypoxic areas are useful for patients that must be treated with radiotherapy...
  36. doi request reprint Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer
    A A Martoni
    Medical Oncology Unit, S Orsola Malpighi University Hospital, Via Albertoni 15, 40138 Bologna, Italy
    Ann Oncol 22:650-6. 2011
    ..The aim of this study was to define its predictive and prognostic values...
  37. ncbi request reprint 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy
    G Martorana
    Department of Urology, Pathology Division, Policlinico S Orsola Malpighi, University of Bologna, Viale Palagi 9, Bologna, Italy
    J Urol 176:954-60; discussion 960. 2006
    ....
  38. ncbi request reprint Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology
    Paolo Castellucci
    Nuclear Medicine Department, Policlinico Sant Orsola Malpighi, Bologna, Italy
    Nucl Med Commun 28:589-95. 2007
    ....
  39. doi request reprint Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma
    Enrico Derenzini
    Institute of Hematology and Medical Oncology L and A Seragnoli, University of Bologna, Bologna, Italy
    Cancer 113:2496-503. 2008
    ....
  40. doi request reprint Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy
    Paolo Castellucci
    Nuclear Medicine Unit, Hematology Oncology and Laboratory Medicine Department, Azienda Ospedaliero Universitaria di Bologna Policlinico S Orsola Malpighi, University of Bologna, Bologna, Italy
    J Nucl Med 50:1394-400. 2009
    ....
  41. doi request reprint Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
    Valentina Ambrosini
    Unità Operativa di Medicina Nucleare, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Padiglione 30, Via Massarenti 9, 40138, Bologna, Italy
    Eur J Nucl Med Mol Imaging 35:1431-8. 2008
    ..At present, there are no comparative studies investigating their role in NET...
  42. doi request reprint Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET
    Stefano Fanti
    Unità Operativa di Medicina Nucleare, Policlinico S Orsola Malpighi, Bologna, Italy
    Biomed Pharmacother 62:667-71. 2008
    ..On the other hand, care has to be paid when studying lesions localized at sites of physiological concentration of the tracer, and in presence of inflammation...
  43. ncbi request reprint 11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma
    Alessandra Maleddu
    Institute of Hematology and Medical Oncology L and A Seragnoli, Sant Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    Tumori 95:382-4. 2009
    ..This case report highlights some interesting points related to the potential role of a novel non-FDG PET tracer, 11C-acetate, in the early prediction of the response to targeted therapies in metastatic renal cell carcinoma...
  44. ncbi request reprint 11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary results
    Giulia Ghigi
    Department of Radiotherapy, Policlinico S Orsola Malpighi Hospital, Bologna, Italy
    In Vivo 23:105-10. 2009
    ....
  45. ncbi request reprint 18F-FDG PET early after radiotherapy in lymphoma patients
    Paolo Castellucci
    U O Medicina Nucleare, PET Unit, Policlinico S Orsola Malpighi, Bologna, Italy
    Cancer Biother Radiopharm 19:606-12. 2004
    ....
  46. doi request reprint 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results
    Cristina Nanni
    Medicina Nucleare, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    J Nucl Med 51:1932-6. 2010
    ..The aim of this work was to preliminarily evaluate the sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy of (68)Ga-citrate PET/CT in a population of patients with suspected bone infections...
  47. doi request reprint 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors
    Valentina Ambrosini
    Department of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi University Hospital, Bologna, Italy
    J Nucl Med 51:669-73. 2010
    ..The aim of this study was to assess the impact of (68)Ga-DOTANOC PET/CT on the clinical management of NET patients...
  48. doi request reprint Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy
    Chiara Fuccio
    Nuclear Medicine Unit, Hematology Oncology and Laboratory Medicine Department, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, University of Bologna, Bologna, Italy
    Ann Nucl Med 24:485-92. 2010
    ..To assess the utility of (11)C-choline PET/CT in the restaging of prostate cancer (PC) patients who showed a single finding on bone scintigraphy (BS) that was classified as equivocal or suspected for metastatic lesion...
  49. ncbi request reprint Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours
    Valentina Ambrosini
    Unità Operativa di Medicina Nucleare, Policlinico S Orsola Malpighi, Bologna, Italy
    Nucl Med Commun 28:473-7. 2007
    ....
  50. doi request reprint Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
    Paolo Castellucci
    Service of Nuclear Medicine, Department of Haematology Oncology and Laboratory Medicine, Azienda Ospedaliero Universitaria di Bologna, Policlinico Sant Orsola Malpighi, University of Bologna, Bologna, Italy
    Eur J Nucl Med Mol Imaging 38:55-63. 2011
    ..5 ng/ml (early biochemical relapse) during follow-up (FU)...
  51. ncbi request reprint The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab
    Francesca Di Fabio
    Medical Oncology Unit, S Orsola Malpighi Hospital, Via Albertoni, 15 40138, Bologna, Italy
    Gastric Cancer 10:221-7. 2007
    ....
  52. doi request reprint 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results
    Valentina Ambrosini
    Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, S Orsola Malpighi Hospital, Bologna, Italy
    J Nucl Med 51:1950-5. 2010
    ..The aim of this study was to evaluate (68)Ga-DOTANOC PET/CT in patients with IPF and NSIP...
  53. doi request reprint Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy
    Andrea A Martoni
    Medical Oncology Unit, S Orsola Malpighi University Hospital, Via Albertoni 15, 40138 Bologna, Italy
    Cancer 116:805-13. 2010
    ..A pathologic complete response (pCR) and minimal residual disease (pMRD) after preoperative chemotherapy (PCT) for early stage or locally advanced breast cancer (BC) correlates with a good prognosis...
  54. ncbi request reprint Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis
    Mohsen Farsad
    Nuclear Medicine Department, PET Unit, Policlinico S Orsola Malpighi, Bologna, Italy
    J Nucl Med 46:1642-9. 2005
    ..This study evaluated the potential usefulness of (11)C-choline PET/CT for detection and localization of tumors within the prostate. We used the results of step-section histopathologic examination as the standard of reference...
  55. ncbi request reprint Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings
    Mohsen Farsad
    UO Medicina Nucleare, Universita di Bologna, Policlinico S Orsola Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    Nucl Med Commun 26:827-30. 2005
    ..Together with the increasing number of clinical settings in which PET/CT scans have been advocated, however, pitfalls in image interpretation have been reported...
  56. ncbi request reprint (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients
    C Nanni
    Nuclear Medicine Department, S Orsola Malpighi Hospital, Bologna, Italy
    Eur J Surg Oncol 31:792-7. 2005
    ..Aim of our study was to evaluate sensitivity, specificity and accuracy of (18)F-FDG PET/CT in a group of patients with suspicion of ovarian cancer recurrence...
  57. doi request reprint A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
    P L Zinzani
    Institute of Hematology and Medical Oncology L and A Seragnoli, University of Bologna, Bologna, Italy
    Ann Oncol 19:769-73. 2008
    ....
  58. ncbi request reprint Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP)
    V Ambrosini
    Nuclear Medicine DIMES, University of Bologna and S Orsola Malpighi Hospital, Bologna, Italy
    Q J Nucl Med Mol Imaging 59:58-69. 2015
    ..This review aims to provide an overview of the current status and clinical application of PET tracers to image well differentiated NEN and to focus on the still open-issues of debate. ..
  59. doi request reprint Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET
    Charoula S Tsamita
    Department of Nuclear Medicine, Institute of Emathology, Policlinico S Orsola Malpighi, Bologna, Italy
    Nucl Med Commun 29:705-10. 2008
    ..The aim of this study was to evaluate the clinical significance of positive axillary findings in patients with Hodgkin's disease and non-Hodgkin's lymphoma during follow-up with 18F-fluorodeoxyglucose-PET...
  60. ncbi request reprint A simple Tracerlab module modification for automated on-column [11C]methylation and [11C]carboxylation
    Filippo Lodi
    Nuclear Medicine Unit, S Orsola Hospital, Bologna, Italy
    Appl Radiat Isot 65:691-5. 2007
    ....
  61. ncbi request reprint 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone
    Cristina Nanni
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Bologna, Italy
    In Vivo 22:513-7. 2008
    ..To evaluate the value of 18F-fluorodeoxy-glucose (FDG) positron emission tomography with computed tomography (PET/CT) in myeloma in patients presenting with a solitary plasmacytoma of bone (SPB)...
  62. doi request reprint 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid
    Valentina Ambrosini
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi Hospital, Bologna, Italy
    Nucl Med Commun 30:281-6. 2009
    ..However, their role in BC has never been evaluated. Our aim is to evaluate the role of 68Ga-DOTA-NOC (68Ga-labelled [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-Nal3-octreotide) PET for the assessment of BC patients...
  63. ncbi request reprint Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results
    Cristina Nanni
    UO Medicina Nucleare, Policlinico S Orsola Malpighi, Via Massarenti, 40100, Bologna, Italy
    Eur J Nucl Med Mol Imaging 33:525-31. 2006
    ..The aim of this study was to compare whole-body X-ray (WBXR), MRI and (18)F-FDG PET/CT in patients with MM...
  64. ncbi request reprint Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET
    Valentina Ambrosini
    Nuclear Medicine Department, Policlinico S Orsola Malpighi, Bologna University, Italy
    Nucl Med Commun 28:647-52. 2007
    ..There are various murine models for human lung adenocarcinoma, but those for squamous cell lung carcinoma, the most common form of human cancer, are lacking...
  65. doi request reprint Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma
    Pier Luigi Zinzani
    Institute of Hematology and Oncology L and A Seragnoli, University of Bologna, Bologna, Italy
    J Clin Oncol 27:1781-7. 2009
    ..However, there are no prospective studies investigating the value of serial FDG-PET over time in patients in complete remission...
  66. ncbi request reprint 18F-DOPA PET and PET/CT
    Cristina Nanni
    S Orsola Malpighi Hospital, Bologna, Italy
    J Nucl Med 48:1577-9. 2007
  67. ncbi request reprint 18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models
    V Ambrosini
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Bologna University Hospital, Bologna, Italy
    Q J Nucl Med Mol Imaging 54:689-97. 2010
    ..To our knowledge, Sorafenib has never been employed in human lymphoma. The aim of the present study was to assess the efficacy of Sorafenib in murine models of human anaplastic large cells lymphoma (ALCL) and Hodgkin lymphoma (HD)...
  68. ncbi request reprint Spinal infection multidisciplinary management project (SIMP): from diagnosis to treatment guideline
    A Gasbarrini
    Rizzoli Orthopaedic Institute, Bologna, Italy
    Int J Immunopathol Pharmacol 24:95-100. 2011
    ....
  69. doi request reprint 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
    E Zamagni
    Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
    Leukemia 30:417-22. 2016
    ..In conclusion, PET/CT positivity significantly increased the risk of progression of SMM to MM. PET/CT could become a new tool to define high-risk SMM. ..
  70. ncbi request reprint Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients
    C Nanni
    Nuclear Medicine Service PET Unit, S Orsola Malpighi Bologna Hospital, Bologna, Italy
    Eur J Nucl Med Mol Imaging 32:589-92. 2005
    ..The aim of this study was to evaluate the potential additional diagnostic role of fused 18F-FDG PET-CT imaging for the detection of metastatic occult primary tumours...
  71. doi request reprint Unusual finding of benign Abrikossoff tumor by F-18 FDG-PET mimicking melanoma recurrence
    Roberto Di Cicilia
    Department of Hematology and Oncological Sciences, S Orsola Malpighi Hospital, L e A Seragnoli, University of Bologna, Bologna, Italy
    Clin Nucl Med 34:696-7. 2009
    ..We present a case of F-18 fluorodeoxyglucose positron emission tomography in Abrikossoff tumor, suggesting that F-18 fluorodeoxyglucose positron emission tomography may have a potential role in the management of this neoplasm...
  72. doi request reprint Small animal PET for the evaluation of an animal model of genital infection
    Cristina Nanni
    Department of Nuclear Medicine, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
    Clin Physiol Funct Imaging 29:187-92. 2009
    ..Since the 1970s, Gallium scintigraphy is a well established test that has been used for the evaluation of inflammation and infection in human patients...
  73. doi request reprint C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma
    Giulia Magini
    Dipartimento di Malattie Apparato Digerente e Medicina Interna, Alma Mater Studiorum, Universita di Bologna, Bologna, Italy
    Clin Nucl Med 34:659-65. 2009
    ....
  74. ncbi request reprint FDG small animal PET permits early detection of malignant cells in a xenograft murine model
    Cristina Nanni
    Nuclear Medicine, Azienda Ospedaliera di Bologna Policlinico S Orsola Malpighi, Bologna, Italy
    Eur J Nucl Med Mol Imaging 34:755-62. 2007
    ..A second goal was to analyse the metabolic behaviour of this xenograft tumour over time...
  75. doi request reprint Reliability and reproducibility of N-[11C]methyl-choline and L-(S-methyl-[11C])methionine solid-phase synthesis: a useful and suitable method in clinical practice
    Filippo Lodi
    Nuclear Medicine Unit, Medical Physics Department, S Orsola Malpighi Hospital, Bologna, Italy
    Nucl Med Commun 29:736-40. 2008
    ..The increasing demand of these radiopharmaceuticals needs robust methods of synthesis with high and reproducible yield which provide enough activity for multiple patient administration in a short synthesis time...
  76. ncbi request reprint Does technetium-99m diethylenetriaminepentaacetate clearance predict the clinical course of idiopathic pulmonary fibrosis?
    Marco Mura
    Unita operativa Fisiopatologia Respiratoria, Policlinico Sant Orsola Malpighi, Bologna
    Can Respir J 11:477-9. 2004
    ..99mTc-DTPA clearance did not show any significant correlation with functional tests or HRCT score. These findings indicate that clearance of inhaled 99mTc-DTPA is not of value in following the progress of IPF...
  77. doi request reprint Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors
    Davide Campana
    Department of Clinical Medicine, Policlinico S Orsola Malpighi Hospital, University of Bologna, Bologna, Italy
    J Nucl Med 51:353-9. 2010
    ..Therefore, we prospectively investigated whether (68)Ga-[1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-NaI3-octreotide ((68)Ga-DOTANOC) PET SUVmax could be used as an accurate noninvasive marker for disease prognosis...
  78. ncbi request reprint Inflammatory activity is still present in the advanced stages of idiopathic pulmonary fibrosis
    Marco Mura
    UO Fisiopatologia Respiratoria, Policlinico Sant Orsola Malpighi, Bologna, Italy
    Respirology 10:609-14. 2005
    ..The aim of this study was to assess the Ga(67) uptake and other markers of inflammation at different stages of IPF and to investigate its prognostic role...
  79. ncbi request reprint Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation
    Paolo Castellucci
    Nuclear Medicine Department, S Orsola Malpighi Hospital, Bologna, Italy
    Nucl Med Commun 26:689-94. 2005
    ....
  80. ncbi request reprint Detection of unknown primary neuroendocrine tumors (CUP-NET) using 68Ga DOTA-NOC receptor PET/CT
    D Hörsch
    Zentralklinik Bad Berka GmbH, Bad Berka, Germany University of Bologna, Bologna, Italy
    J Clin Oncol 27:4599. 2009
    ..4599 Background: This bi-centric study aimed at determining the role of receptor PET/CT using 68Ga-DOTA-NOC in the detection of undiagnosed primary sites of neuroendocrine tumours (NETs)...
  81. ncbi request reprint Use of PET/CT to evaluate response to therapy in lymphoma
    L Zanoni
    PET Division, Nuclear Medicine Department, University Hospital Sant Orsola Malpighi, Bologna, Italy
    Q J Nucl Med Mol Imaging 55:633-47. 2011
    ..We reviewed, from a nuclear medicine point of view and a clinical point of interest, evidence for the use of FDG-PET in monitoring early and end treatment response...
  82. doi request reprint Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ)
    Pier Luigi Zinzani
    Institute of Haematology and Medical Oncology L and A Seragnoli, University of Bologna, Bologna, Italy
    Lancet Oncol 9:352-8. 2008
    ....
  83. ncbi request reprint Diagnostic role of 18F-FDG PET in gastric MALT lymphoma
    Valentina Ambrosini
    Department of Nuclear Medicine PET Unit, Policlinico S Orsola Malpighi Hospital, Bologna, Italy
    Nucl Med Rev Cent East Eur 9:37-40. 2006
    ..The aim of the study was to evaluate the usefulness of 18F-FDG-PET in patients with gastric lymphoma, in particular those affected by mucosa-associated lymphoid tissue (MALT) type and aggressive gastric non-Hodgkin's lymphoma (NHL)...
  84. ncbi request reprint Additional value of hybrid PET/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma
    Valentina Ambrosini
    Nuclear Medicine Service PET Unit, Policlinico S Orsola Malpighi, Bologna University, Bologna, Italy
    Nucl Med Rev Cent East Eur 8:111-5. 2005
    ..In some preliminary studies, (18)F-FDG PET has proven to be able to provide useful information for staging purpose, especially for the detection of metastatic spread to lymph nodes and distant sites...
  85. ncbi request reprint Role of 18F-FDG PET for evaluating malignant pleural mesothelioma
    Cristina Nanni
    Unità Operativa Medicina Nucleare, Bologna, Italy
    Cancer Biother Radiopharm 19:149-54. 2004
    ..In conclusion, FDG PET was found to play a worth-while role in patient management...
  86. ncbi request reprint Somatostatin receptor scintigraphy for bronchial carcinoid follow-up
    Stefano Fanti
    Nuclear Medicine Unit, Ploivlinico S Orsola Malpighi, Universita degli Studi, Bologna, Italy
    Clin Nucl Med 28:548-52. 2003
    ..The aim of this study was to evaluate the role of SRS in restaging BC and following patients after treatment...
  87. ncbi request reprint A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma
    Elena Zamagni
    Istituto di Ematologia ed Oncologia Medica Seràgnoli Università degli Studi di Bologna, Policlinico S Orsola Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    Haematologica 92:50-5. 2007
    ....
  88. doi request reprint Positron-emission tomography in gynaecologic malignancies
    Anna Margherita Maffione
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Bologna, Italy
    Arch Gynecol Obstet 280:521-8. 2009
    ..However, this under utilisation is being actively re-addressed with a large number of reviews and studies, particularly in the last few years...
  89. doi request reprint Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma
    Anna Margherita Maffione
    Unità Operativa di Medicina Nucleare, Policlinico S Orsola Malpighi, Bologna, Italy
    Clin Nucl Med 34:777-8. 2009
    ..This case indicates that after completion of radioimmunotherapy it may be recommended to wait several weeks before performing a PET scan and, in case of minimal findings, to consider a short-term re-evaluation...
  90. ncbi request reprint Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma
    Pier Luigi Zinzani
    Institute of Hematology and Oncology L and A Seragnoli, University of Bologna, Bologna, Italy
    Haematologica 92:771-7. 2007
    ..The aim of this retrospective study was to verify the reliability of positive PET scans of the mediastinum in following up patients with mediastinal lymphoma, using histological findings as a comparison...
  91. doi request reprint A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma
    Pier Luigi Zinzani
    Institute of Hematology and Medical Oncology L and A Seragnoli, University of Bologna, Bologna, Italy
    Cancer 112:856-62. 2008
    ....
  92. ncbi request reprint Significance of posture and workload in exercise renography
    Stefano Fanti
    Department of Nuclear Medicine, Maggiore Hospital, Bologna, Italy
    Nucl Med Rev Cent East Eur 9:41-5. 2006
    ..The second aim was to assess whether the severity of hypertension had any influence on the development of exercise related renal dysfunction...
  93. doi request reprint Small animal PET in oncology: the road from bench to bedside
    Valentina Ambrosini
    Department of Nuclear Medicine, Policlinico S Orsola Malpighi, Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy
    Cancer Biother Radiopharm 24:277-85. 2009
    ..This review focuses on the applications of SA-PET for the visualization of the pathophysiologic pathways of tumor cells...
  94. ncbi request reprint Role of small animal PET for molecular imaging in pre-clinical studies
    Cristina Nanni
    UO Medicina Nucleare, Azienda Ospedaliero Universitaria di Bologna Policlinico S Orsola Malpighi, Bologna, Italy
    Eur J Nucl Med Mol Imaging 34:1819-22. 2007
  95. ncbi request reprint Somatostatin receptor (SSTR) scintigraphy in patients with osteosarcoma
    Stefano Ferrari
    Musculoskeletal Oncology Department of the Istituto Ortopedico Rizzoli, Bologna, Italy
    Cancer Biother Radiopharm 18:847-51. 2003
    ....
  96. doi request reprint Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients
    Pier Luigi Zinzani
    Institute of Hematology and Medical Oncology L e A Seràgnoli, Policlinico Sant Orsola Malpighi, University of Bologna, Via Massarenti 9, Bologna, Italy
    Clin Cancer Res 16:3998-4004. 2010
    ....
  97. ncbi request reprint Exercise renal scintigraphy shows renal ischemia in a transplanted kidney
    Stefano Fanti
    Division of Nuclear Medicine, S Orsola Malpighi Hospital, Bologna, Italy
    Clin Nucl Med 27:483-5. 2002
    ..A "steal phenomenon" of the kidney related to ambulation was considered likely. Ischemia of the transplanted kidney was revealed by exercise renography, which showed parenchymal trapping of radiotracer as a result of exercise...
  98. ncbi request reprint Abnormal cardiac innervation in patients with idiopathic ventricular fibrillation
    Mauro Biffi
    Istitute of Cardiology, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy
    Pacing Clin Electrophysiol 26:357-60. 2003
    ..Patients with idiopathic VF exhibit the same distribution, though have a significantly greater density of sympathetic terminals in the anterolateral segments than controls, which may promote ventricular arrhythmias...
  99. ncbi request reprint Scintigraphic findings in necrotizing myopathy
    Christina Nanni
    U O Medicina Nucleare, Bologna, Italy
    Clin Nucl Med 28:118-20. 2003
    ..The authors present a case of this infrequently occurring disease, describe an unusual scintigraphic pattern, and show tracer uptake localized in soft tissues rather than the skeleton...
  100. ncbi request reprint Value of PET-CT fusion imaging in avoiding potential pitfalls in the interpretation of 18F-FDG accumulation in the distal oesophagus
    Lucia Rampin
    Eur J Nucl Med Mol Imaging 32:990-2. 2005
  101. ncbi request reprint 18F-FDG PET in malignant lymphoma: significance of positive findings
    Paolo Castellucci
    UO Medicina Nucleare, Policlinico S Orsola Malpighi, Via Massarenti, Bologna 40100 Italy
    Eur J Nucl Med Mol Imaging 32:749-56. 2005
    ..The aim of this study was to evaluate the significance of increased uptake of 18F-fluorodeoxyglucose (FDG) in patients with malignant lymphoma (ML) studied by positron emission tomography (PET)...